Forcyte Biotechnologies, Inc. SBIR Phase I Award, April 2018
A SBIR Phase I contract was awarded to Forcyte Biotechnologies in April, 2018 for $288,031.0 USD from the U.S. Department of Health & Human Services and National Institutes of Health.
Currently, there are no issues on this topic.
Find more entities like Forcyte Biotechnologies, Inc. SBIR Phase I Award, April 2018
Use the Golden Query Tool to find similar entities by any field in the Knowledge Graph, including industry, location, and more.
By using this site, you agree to our Terms of Service.